India’s Life Sciences Industry Poised for the Next Level

By Kiran Mazumdar-Shaw Over the last 20 years, life sciences in India has gone from being a nascent sector to a sunrise industry. When I began my own entrepreneurial journey in 1978, little did I know that I was sowing the seeds of the country’s biotechnology revolution. Up until the mid-1980s, I was the lone … Continue reading India’s Life Sciences Industry Poised for the Next Level

The Pandemic has Unleashed Opportunities We Never Thought Existed

By Kiran Mazumdar-Shaw, Executive Chairperson, Biocon & Biocon Biologics The tectonic shifts that the COVID-19 pandemic brought with it has thrust the Indian biotechnology industry into the global limelight. The industry responded with grit, agility and creativity to address India’s healthcare needs in the face of a rampaging viral outbreak. This global emergency galvanized India’s … Continue reading The Pandemic has Unleashed Opportunities We Never Thought Existed

A game-changing, transformational deal that is an inflection point in Biocon Biologic’s journey of making global impact: Kiran Mazumdar-Shaw

A game-changing, transformational deal that is an inflection point in Biocon Biologic’s journey of making global impact: Kiran Mazumdar-Shaw

Biocon Biologics on Monday announced a transformational deal to acquire partner Viatris’ global biosimilars business for up to USD 3.335 billion in cash and stock. The acquisition of the business, which is estimated to generate revenues of USD 1 billion next year, will create a unique, fully integrated global biosimilars enterprise. Kiran Mazumdar-Shaw, Executive Chairperson, … Continue reading A game-changing, transformational deal that is an inflection point in Biocon Biologic’s journey of making global impact: Kiran Mazumdar-Shaw

The Biocon Biologics-Viatris Transaction Catapults us into The Global Big League

Biocon Biologics on Monday announced a transformational deal to acquire partner Viatris’ global biosimilars business for up to USD 3.335 billion in cash and stock. The acquisition of the business, which is estimated to generate revenues of USD 1 billion next year, will create a unique, fully integrated global biosimilars enterprise. Kiran Mazumdar-Shaw, Executive Chairperson, … Continue reading The Biocon Biologics-Viatris Transaction Catapults us into The Global Big League

Technology holds huge promise for healthcare in India in 2022

By Kiran Mazumdar-Shaw The COVID-19 pandemic has caused a digital disruption in healthcare. It has accelerated innovation, catalysed technological breakthroughs, and created a fertile environment for the emergence of low-cost innovations anchored in affordability, and accessibility. It has also forced changes in consumer behaviour, persuaded doctors to become tech-savvy, prompted pharma companies to invest in … Continue reading Technology holds huge promise for healthcare in India in 2022

Healthcare for all must be built on the voices of all

The state of health care in India is far from optimal, a statement with which few of its 1.3 billion citizens would disagree. Even prior to the pandemic, reforming the health system was overdue, evidenced by poor health indicators, unequal delivery of quality care and inadequate protection from financial risk. Despite significant improvements in areas … Continue reading Healthcare for all must be built on the voices of all

World needs to balance risks, benefits and challenges of deploying COVID-19 vaccines

Biocon Executive Chairperson Kiran Mazumdar-Shaw recently spoke at Carnegie India’s Global Technology Summit, which convened leading policymakers, entrepreneurs, industry leaders, academics and technologists from around the world to deliberate over five days on an overarching theme of ‘Geopolitics of Technology’. On Dec. 18, 2020, the last day of the summit, Ms Mazumdar-Shaw joined Soumya Swaminathan, … Continue reading World needs to balance risks, benefits and challenges of deploying COVID-19 vaccines

Fostering MedTech Innovation in India

India's first corporate hospital-based technology business incubator for MedTech entrepreneurs - the Mazumdar Shaw Medical Foundation (MSMF) MedTech Innovation Center - was inaugurated at Narayana Health City Bangalore, in collaboration with BIRAC, Bionest program, on Dec 15, 2020. Launching the facility, Ms. Kiran Mazumdar-Shaw, founder of MSMF and Executive Chairperson, Biocon said the centre will … Continue reading Fostering MedTech Innovation in India

India Has Potential to Increase Covid Testing 10-Fold, Kiran Mazumdar-Shaw Says

India has the ability to aggressively ramp up coronavirus testing capacity, a move that will help it check a wave of new active cases hitting hospitals and skirt an economically unviable lockdown, according to Ms. Kiran Mazumdar-Shaw, the founder and chairman of Biocon Ltd.  With pooled testing that can include as many as 10 people in one … Continue reading India Has Potential to Increase Covid Testing 10-Fold, Kiran Mazumdar-Shaw Says

Kiran Mazumdar-Shaw Promises to Enable Universal Access to rh-Insulin by Reducing Prices to Less than 10 US cents/Day for LMICs

Kiran Mazumdar Shaw speaks at the UNAIDS Health Innovation Exchange Meeting on the sidelines of United Nations General Assembly, held in New York on 25th September 2019. Your Excellencies, Distinguished Ladies and Gentlemen, We have just witnessed the first UN High Level meeting on Universal Health Care on Monday. Governments have a collective moral responsibility … Continue reading Kiran Mazumdar-Shaw Promises to Enable Universal Access to rh-Insulin by Reducing Prices to Less than 10 US cents/Day for LMICs